HomeInsightsStock Comparison

Pfizer Ltd vs Windlas Biotech Ltd Stock Comparison

Pfizer Ltd vs Windlas Biotech Ltd Stock Comparison

Last Updated on: May 29, 2025

Key Highlights

  • The Latest Trading Price of Pfizer Ltd is ₹ 5576 as of 29 May 11:37.
  • The P/E Ratio of Pfizer Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Windlas Biotech Ltd changed from 12 on March 2022 to 18.3 on March 2024 . This represents a CAGR of 15.10% over 3 years.
  • The Market Cap of Pfizer Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Windlas Biotech Ltd changed from ₹ 457.9 crore on March 2022 to ₹ 1065 crore on March 2024 . This represents a CAGR of 32.52% over 3 years.
  • The revenue of Pfizer Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Windlas Biotech Ltd for the Mar '25 is ₹ 207.64 crore as compare to the Dec '24 revenue of ₹ 199.13 crore. This represent the growth of 4.27%.
  • The ebitda of Pfizer Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Windlas Biotech Ltd for the Mar '25 is ₹ 30.49 crore as compare to the Dec '24 ebitda of ₹ 28.74 crore. This represent the growth of 6.09%.
  • The net profit of Pfizer Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of Windlas Biotech Ltd changed from ₹ 12.07 crore to ₹ 16.28 crore over 8 quarters. This represents a CAGR of 16.14% .
  • The Dividend Payout of Pfizer Ltd changed from 296.54 % on March 2020 to 29.04 % on March 2024 . This represents a CAGR of -37.17% over 5 yearsThe Dividend Payout of Windlas Biotech Ltd changed from 19.79 % on March 2022 to 19.68 % on March 2024 . This represents a CAGR of -0.19% over 3 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Pfizer Ltd

  • Pfizer Limited is engaged in manufacturing, marketing, trading and export of pharmaceutical products.
  • The Company offer a portfolio of 150 specialised medicines in 15 therapeutic areas across 4 business categories.
  • It has its own manufacturing facility at Goa and Thane.
  • It has the distinction of being the first pharmaceutical company in India to start clinical research.
  • The Company sells products in nearly 185 countries having 43 manufacturing sites globally.

About Windlas Biotech Ltd

  • Windlas Biotech Limited (formerly known as Windlas Biotech Private Limited) was incorporated in 2001.
  • The Company converted from a Private Limited Company to a Public Limited Company and the name of the Company was changed to Windlas Biotech Limited'.
  • A fresh Certificate of Incorporation dated April 15, 2021, granted by the Registrar of Companies, Uttarakhand at Dehradun. The Company is engaged in manufacturing and trading of pharmaceutical products.
  • TheIR manufacturing facilities are located at Dehradun in Uttarakhand.
  • It also has a sales force and distribution network spread across 14 states.

Pfizer Ltd News Hub

News

Pfizer to hold AGM

Pfizer announced that the 74th Annual General Meeting(AGM) of the company will be held on ...

Read more

21 May 2025 11:43

News

Board of Pfizer recommends final dividend

Pfizer announced that the Board of Directors of the Company at its meeting held on 19 May ...

Read more

20 May 2025 12:47

News

Board of Pfizer recommends special dividend

75th year of Pfizer announced that the Board of Directors of the Company at its meeting he...

Read more

20 May 2025 12:46

News

Board of Pfizer recommends special dividend

Pfizer announced that the Board of Directors of the Company at its meeting held on 19 May ...

Read more

20 May 2025 12:46

News

Pfizer gallops after good Q4 outcome

Pfizer reported an exceptional profit of Rs 172.81 crore in Q4 March 2025, primarily due t...

Read more

20 May 2025 12:57

News

Volumes jump at Pfizer Ltd counter

BASF India Ltd, NLC India Ltd, Zensar Technologies Ltd, Newgen Software Technologies Ltd a...

Read more

20 May 2025 14:30

Windlas Biotech Ltd News Hub

News

Windlas Biotech Ltd Slips 4.88%, BSE Healthcare index Shed 1.03%

Windlas Biotech Ltd fell 4.88% today to trade at Rs 923. The BSE Healthcare index is down ...

Read more

23 May 2025 09:30

News

Board of Windlas Biotech recommends final dividend

Windlas Biotech announced that the Board of Directors of the Company at its meeting held o...

Read more

22 May 2025 21:08

News

Windlas Biotech to announce Quarterly Result

Windlas Biotech will hold a meeting of the Board of Directors of the Company on 22 May 202...

Read more

15 May 2025 12:29

News

Windlas Biotech receives affirmation in credit ratings from ICRA

Windlas Biotech has received reaffirmation in credit ratings from ICRA at ICRA A+; Stable/...

Read more

08 Apr 2025 15:08

News

Windlas Biotech to hold board meeting

Windlas Biotech will hold a meeting of the Board of Directors of the Company on 11 Februar...

Read more

04 Feb 2025 10:43

News

Windlas Biotech receives GMP certification for its new state-of-the-art injectable facility

Windlas Biotech announced that it has received Good Manufacturing Practices (GMP) certific...

Read more

10 Jan 2025 15:42

SWOT Analysis Of Pfizer Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Windlas Biotech Ltd

Strength

5

S

Weakness

3

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Pfizer Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Windlas Biotech Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Pfizer Ltd and Windlas Biotech Ltd

Which company has a larger market capitalization, Pfizer Ltd or Windlas Biotech Ltd?

Market cap of Pfizer Ltd is 25,183 Cr while Market cap of Windlas Biotech Ltd is 1,957 Cr

What are the key factors driving the stock performance of Pfizer Ltd and Windlas Biotech Ltd?

The stock performance of Pfizer Ltd and Windlas Biotech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Pfizer Ltd and Windlas Biotech Ltd?

As of May 29, 2025, the Pfizer Ltd stock price is INR ₹5504.8. On the other hand, Windlas Biotech Ltd stock price is INR ₹936.45.

How do dividend payouts of Pfizer Ltd and Windlas Biotech Ltd compare?

To compare the dividend payouts of Pfizer Ltd and Windlas Biotech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions